Natera Sees FY24 SG&A $775M-$825M; R&D $375M-$400M' Net Cash Inflows $50M-$75M.

Benzinga24minutes ago

Natera Sees FY24 Revenue $1.61B-$1.64B Vs $1.518B Est

Benzinga25minutes ago

Natera Q3 2024 GAAP EPS $(0.26) Beats $(0.58) Estimate, Sales $439.800M Beat $361.450M Estimate

Benzinga28minutes ago

Illumina Coverage Resumed at Equal Weight by Morgan Stanley

Seeking Alpha04:13

ARKK's Holdings Ranked by SA Quant Grades

Seeking Alpha03:21

How Is The Market Feeling About Intuitive Surgical?

Benzinga01:00